Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer
about
Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancersMethylated circulating tumor DNA in blood: power in cancer prognosis and responseCharacterization of DNA Methylation in Circulating Tumor CellsEpigenetic gene silencing by the SRY protein is mediated by a KRAB-O protein that recruits the KAP1 co-repressor machinerySox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.Sox17 promotes cell cycle progression and inhibits TGF-beta/Smad3 signaling to initiate progenitor cell behavior in the respiratory epithelium.Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patientsSessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract.Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors.Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiationGenistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1.SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the Wnt/β-catenin pathway.Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionClinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas.Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.Cancer epigenetics: linking basic biology to clinical medicine.Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonistsInteractions between SOX factors and Wnt/beta-catenin signaling in development and diseaseThe SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancerMolecular marks for epigenetic identification of developmental and cancer stem cellsGenome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.The Sox transcriptional factors: Functions during intestinal development in vertebrates.Genome-wide positioning of bivalent mononucleosomes.Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer.TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.DNA methylation biomarker candidates for early detection of colon cancer.Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.5-Azacytidine suppresses EC9706 cell proliferation and metastasis by upregulating the expression of SOX17 and CDH1.DNA methylation and cancer pathways in gastrointestinal tumors.Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors.
P2860
Q21134689-B04E74B7-096F-410E-A8DD-391E44F277BAQ26772077-293732E9-8162-4EDC-93E0-760CBE4E35E1Q26778427-73D5A0C6-4F4C-4DEB-8F66-1ADEDAD69256Q28512720-FB1B4D59-3799-447C-A54F-B90CB4D9BA08Q29347266-75C499D9-242B-4284-A471-EAFB164D2A39Q30504615-06DBABAB-7272-42FB-BC5B-0B7D1700364CQ33455690-B9566A90-8024-4230-8107-7B66015FCBA6Q33754679-3E594672-F34F-4335-A655-156E1BEA54B2Q33770826-A8B5D1D9-3972-4B59-BC2A-921D51F2C851Q33771084-E70B633F-4BF3-417E-B5B0-B6B0927299D3Q33771090-9ECE47D4-ADB8-40D7-AB93-E3254845F316Q33798842-E9729BB6-DB28-41E9-BAE4-96946F15B9F0Q34075626-3C0CE0ED-CB17-4000-B215-33859594FB0BQ34170505-33932DE2-D97C-468D-BC3D-9BE5CC0A1A54Q34334482-D37C3757-504E-42E9-9CD6-36F4863C4E20Q34396048-A681E92A-FD1D-4D1A-A50F-8C7DDDAE525EQ34512240-7C6E8EAA-2EB5-45F7-B842-BC34A4FF9DBBQ34786506-0C20E8A7-41D9-4936-A98A-4117D412D414Q34925594-E651D067-68E4-401B-8AF7-1CBEB6B8C4A5Q34984574-AD0AF566-ECFB-492F-BB2A-32447D1958EFQ35038503-259220CF-994F-4288-B5EF-2CD080051A3FQ35071360-19A1BB51-4837-4B60-93D1-3B6C2FCD6439Q35167200-9C9C1818-F4A8-4A9E-9FD1-DBB15425DDAEQ35348043-0523B11C-B82F-4509-970D-3D7DB28BAF64Q35402307-5AD05E77-BC5A-46ED-AE32-C6CFE0A91B57Q35459134-09CE79A9-CBF2-4DC4-96DE-2616B762DAD9Q35719925-52E79444-E8FA-4BAB-B1C0-C4B523A388DDQ35832308-EE186898-F96A-4589-A83F-604031A3E647Q36001860-53542DCC-192B-437D-8D44-4395758FD39BQ36093867-19062512-5190-48A3-89A2-99AD8D1F9B82Q36115146-890D2626-DB12-45E0-AA98-65CF64AEEDCAQ36135171-0A3E8DCE-2928-4504-BE73-1FC63158CCE9Q36151111-C091A34C-6857-4D0B-9229-0D9F23EB7932Q36212916-A909BFA0-0C7B-454F-9F1D-A5B941EA2411Q36225166-D805ED40-4DC3-438B-B7F2-5BB4500F3186Q36672397-F29914DD-E69E-4E3B-B795-D02719037D16Q36906155-CD1E59C4-172B-419A-925E-9A70FD7B0AD0Q37269937-59AE60B6-94C8-4F21-AA6D-15AC40055913Q37346219-1B467E04-D4A0-45A5-8DA9-EE82CA0825F4Q37347838-3DD10975-E260-49C0-9AA3-FF82E5E30893
P2860
Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@ast
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@en
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@en-gb
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@nl
type
label
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@ast
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@en
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@en-gb
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@nl
prefLabel
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@ast
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@en
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@en-gb
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@nl
P2093
P2860
P921
P3181
P1433
P1476
Epigenetic inactivation of the ...... g gene 17 in colorectal cancer
@en
P2093
D Neil Watkins
David H Wang
Emi Ota Machida
James G Herman
Kornel E Schuebel
Leander Van Neste
Mingzhou Guo
Nita Ahuja
Sabine C Glöckner
Stephen B Baylin
P2860
P304
P3181
P356
10.1158/0008-5472.CAN-07-6349
P407
P577
2008-04-01T00:00:00Z